Search results
Earnings call: Rigel Pharmaceuticals Q1 2024 performance and outlook
Investing.com· 4 days agoThe company also announced the acquisition of GAVRETO, a therapy approved for specific types of...
EnviroGold Global Announces Filing of New Patent Application Completing Intellectual Property...
Benzinga· 4 days agoThis patent application, combined with the previously filed Application PCT AU2023/051121 for an improved process for recovery of refractory ores, completes the suite of intellectual ...
Earnings call: Oncternal reports Q1 results and clinical progress
Investing.com· 2 days agoOncternal Therapeutics Inc. (ONCT) provided a comprehensive update on its business and financial...
Insmed (INSM) Beats on Q1 Earnings, Posts Upbeat Pipeline Updates
Zacks· 2 days agoInsmed (INSM) Q1 earnings beat estimates while sales miss the mark. Management posts positive data readouts from mid-stage studies on its experimental inhalation powder in PH-ILD and PAH indications.
Beyond the Balance Sheet: What SWOT Reveals About Shockwave Medical Inc (SWAV)
GuruFocus.com via Yahoo Finance· 5 days agoThe opportunities for international expansion and the potential acquisition by Johnson & Johnson...
Marinus lays off 20% of staff to steady ship after IV seizure med's phase 3 struggles
FierceBiotech· 4 days agoNow, Marinus has revealed that the strategy will involve reducing its head count by around 20% as...
Arcellx Inc (ACLX) Q1 2024 Earnings: Narrower Losses and Revenue Surge
GuruFocus.com via Yahoo Finance· 2 days agoThe company is currently advancing its lead product candidate, anito-cel, in a Phase 2 pivotal trial for the treatment of relapsed or refractory multiple ...
GlycoMimetics reports Phase 3 trial of uproleselan falls short By Investing.com
Investing.com· 6 days agoThe study aimed to determine the efficacy of uproleselan in improving survival rates when used...
Trevi Therapeutics Reports Q1 2024 Financial Results: A Detailed
Guru Focus· 4 days agoThe company, known for developing the investigational therapy Haduvio for chronic cough and prurigo nodularis, revealed both its current financial standing and progress...
Ligand (LGND) Beats Q1 Earnings, Misses Sales Estimates
Zacks via Yahoo Finance· 4 days agoMarinus Pharmaceuticals also provided an update on the late-stage RAISE study evaluating IV...